Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ALG1 like 6, pseudogene (ALG1L6P) is a pseudogene in Homo sapiens. Pseudogenes are genomic DNA sequences similar to normal genes but typically nonfunctional due to mutations or lack of regulatory elements, and they do not encode functional proteins. There is no evidence that ALG1L6P has any protein-coding function, biological role, or involvement in disease processes, and it is not recognized as a therapeutic target[3][5]. ALG1L6P is classified as a pseudogene, meaning it is a “defunct” gene copy that does not produce a functional protein[3][5]. There are no established aliases used in biomedical literature beyond the standardized gene symbol[3]. No information links ALG1L6P to a protein product, receptor/enzymatic/transporter activity, or therapeutic modulation. There are no known biological functions, disease involvements, drugs, or safety concerns associated with ALG1L6P[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ALG1 like 6, pseudogene (ALG1L6P).